Source:http://linkedlifedata.com/resource/pubmed/id/16110415
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
2005-8-19
|
| pubmed:abstractText |
Matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) play a crucial role in physiological and pathological matrix turnover. This study aimed to determine the occurrence of MMP and TIMP in lung cancer patients with malignant pleural effusions (CA).
|
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0934-8387
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
59
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
523-8
|
| pubmed:dateRevised |
2009-4-7
|
| pubmed:meshHeading |
pubmed-meshheading:16110415-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:16110415-Humans,
pubmed-meshheading:16110415-Lung Neoplasms,
pubmed-meshheading:16110415-Matrix Metalloproteinases,
pubmed-meshheading:16110415-Pleural Effusion, Malignant,
pubmed-meshheading:16110415-Tissue Inhibitor of Metalloproteinases
|
| pubmed:year |
2005
|
| pubmed:articleTitle |
[Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion].
|
| pubmed:affiliation |
Medizinische Klinik und Poliklinik I, Abteilung Pneumologie, Universität Leipzig.
|
| pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|